Vitamin D compounds as potential therapeutics for estrogen-independent breast cancer

Nutrition

Volumn 13, Issue 10, 1997, Pages 915-917

  Welsh, Joellen ^a  

^a Adirondack Biomedical Research Institute Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

22 OXACALCITRIOL; CALCITRIOL; FULVESTRANT; SEOCALCITOL; VITAMIN D DERIVATIVE; VITAMIN D RECEPTOR;

ANTINEOPLASTIC ACTIVITY; BREAST CANCER; CANCER RESEARCH; CELL STRAIN MCF 7; DRUG RESEARCH; DRUG SCREENING; HUMAN; NOTE; PRIORITY JOURNAL;

BREAST NEOPLASMS; ESTROGENS; FEMALE; HUMANS; VITAMIN D;

EID: 0030730640     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(97)00258-X     Document Type: Note

References (22)

1. Welsh JE, Simboli-Campbell M, Narvaez CJ, Tenniswood M. Role of apoptosis in the growth inhibitory effects of vitamin D in MCF-7 cells. Adv Exp Biol Med 1995;375:45
2. Kyprianou N, English H, Davidson N, Isaacs J. Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation. Cancer Res 1991;51:162
3. 3 inhibitory effect on the growth of two human breast cancer cell lines (MCF-7, BT-20). J Steroid Biochem 1986;24:373
4. 3 on cell cycle kinetics of T47D human breast cancer cells. J Cell Physiol 1989;138:611
5. Studzinski G, McLane JA, Uskokovic M. Signalling pathways for vitamin D induced differentiation: implications for therapy of proliferative and neoplastic diseases. Crit Rev Eukaryot Gene Expr 1993;3:279
6. 3 receptor in human breast cancer. Cancer Res 1981;41:5121
7. 3 receptor in breast cancer and relationship to prognosis. Cancer Res 1991;51:239
8. Buras R, Schumaker LM, Davoodi F, et al. Vitamin D receptors in breast cancer cells. Breast Cancer Res Treat 1994;31:191
9. Mezettie G, Monti MG, Casolo P, Piccinini G, Moruzzi MS. 1,25-Dihydroxycholecalciferol dependent calcium uptake by mouse mammary gland in culture. Endocrinology 1988;122:389
10. Battcharjee M, Weintroub S, Vonderhaar BK. Milk protein synthesis of vitamin D deficient mice. Endocrinology 1987;121:865
11. 3 and its analogues on induction of apoptosis in breast cancer cells. J Steroid Biochem Mol Biol 1996;58:395
12. 3 and EB1089 on cell cycle kinetics and apoptosis in MCF-7 cells. Breast Cancer Res Treat 1997;42:31.
13. 3 induces morphological and biochemical indices of apoptosis in MCF-7 breast cancer cells. J Steroid Biochem Mol Biol 1996;58:367
14. James SY, Mackay A, Binderup L, Colston K. Effects of a new synthetic vitamin D analogue, EB1089, on the oestrogen responsive growth of human breast cancer cells. J Endocrinol 1994;141:555
15. 3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cells. Cancer Res 1995;55:2822
16. 3 analogues in breast cancer cells. Cancer Res 1996;56:2789
17. 3 analogues and tamoxifen. Cancer Res 1994;54:5711
18. 3 resistant MCF-7 cell line. Endocrinology 1996;137:400
19. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 1996;10:142
20. 3 analogue that inhibits the growth of breast cancer cells in vivo and in vitro. Biochem Pharmacol 1992;44:2273
21. 3, inhibits the growth of human breast cancer in vitro and in vivo without causing hypercalcemia. Endocrinology 1991;129:832
22. Abe-Hashimoto J, Kikuchi T, Matsumoto T, Nishii Y, Ogata E, Ikeda K. Antitumor effect of 22-oxa-calcitriol, a noncalcemic analogue of calcitriol, in athymic mice implanted with human breast carcinoma and its synergism with tamoxifen. Cancer Res 1993;53:2534